Moreover, high expression of EPAS1/HIF2α, AREG and WISP2 is linked to improved survival in breast cancer [50]; glyceollin treatment does not affect EPAS1/HIF2α expression in the absence of E2 treatment and even partially restores expression in E2-treated cells. The gene discussed is EPAS1; the disease is breast carcinoma.